Remember
 
 
At SpeculatingStocks You Can Discover Stocks, Post Anonymously, and React to Posts. Login is Optional.
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

February 18, 2005

SpeculatingStocks.com Stock Pick: Cell Therapeutics, Inc. (CTIC)

Stock Price: $10.00


Cell Therapeutics, Inc. (CTI) develops, acquires and commercializes novel treatments for cancer. The Company's research and in-licensing activities are concentrated on identifying new, less toxic and more effective ways to treat cancer.

The company is releasing fourth quarter and year end numbers on February 28th; however, the bigger catalyst for CTIC will be the results from their Xyotax drug study. Results from Phase III studies are now expected to be released in early March to mid-March instead of April, previously reported. The market took this as good news and drove CTIC up 12%.

As a warning, biotech stocks are extremely risky, if a drug falls through trials the stock usually plummets.

The picture right now looks good for CTIC, it has been in a strong uptrend since late last summer when it was under $5.00.

 
     
Untitled Document